Bioxytran, Inc SEC filings BIXT
Bioxytran, Inc has 470 filings in SEC EDGAR's recent list, going back to Oct 31, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B4 | Prospectus | Feb 18, 2025 | — |
| S-1/A | Amended registration statement | Feb 12, 2025 | — |
| S-1/A | Amended registration statement | Feb 5, 2025 | — |
| S-1 | Registration statement | Jan 22, 2025 | — |
| 424B4 | Prospectus | Oct 2, 2023 | — |
| S-1/A | Amended registration statement | Sep 26, 2023 | — |
| S-1 | Registration statement | Sep 19, 2023 | — |
| 424B4 | Prospectus | Aug 15, 2023 | — |
| S-1/A | Amended registration statement | Aug 9, 2023 | — |
| S-1/A | Amended registration statement | Aug 3, 2023 | — |
| S-1/A | Amended registration statement | Jul 13, 2023 | — |
| S-1/A | Amended registration statement | Jul 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 30, 2023 | — |
| S-1 | Registration statement | Jun 16, 2023 | — |
| S-1 | Registration statement | Apr 12, 2022 | — |
| 424B4 | Prospectus | Jul 26, 2021 | — |
| 424B4 | Prospectus | Jul 26, 2021 | — |
| S-1/A | Amended registration statement | Jul 20, 2021 | — |
| S-1 | Registration statement | Jun 24, 2021 | — |
| 424B4 | Prospectus | Feb 14, 2019 | — |
| 424B4 | Prospectus | Feb 14, 2019 | — |
| S-1/A | Amended registration statement | Feb 12, 2019 | — |
| S-1/A | Amended registration statement | Feb 1, 2019 | — |
| S-1/A | Amended registration statement | Jan 30, 2019 | — |
| S-1 | Registration statement | Nov 30, 2018 | — |
| S-8 | Employee stock plan registration | Aug 29, 2016 | — |
| S-8 | Employee stock plan registration | Apr 18, 2013 | — |
| S-8 | Employee stock plan registration | Feb 22, 2010 | — |
| 424B3 | Prospectus | Apr 10, 2009 | — |
| S-1/A | Amended registration statement | Apr 8, 2009 | — |
| S-1/A | Amended registration statement | Apr 7, 2009 | — |
| S-1/A | Amended registration statement | Apr 3, 2009 | — |
| S-1/A | Amended registration statement | Mar 19, 2009 | — |
| S-1/A | Amended registration statement | Mar 3, 2009 | — |
| S-1/A | Amended registration statement | Feb 4, 2009 | — |
| S-1/A | Amended registration statement | Dec 24, 2008 | — |
| S-1 | Registration statement | Oct 31, 2008 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIXT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Needham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1445815
- Former names
- U.S. RARE EARTH MINERALS, INC. (until Oct 30, 2018); U.S. RARE EARTH MINERALS, INC (until Oct 3, 2018); U.S. Natural Nutrients & Minerals, Inc. (until Apr 14, 2011); AMERICA'S DRIVING RANGES, INC. (until Oct 29, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.